FORGOT YOUR DETAILS?

  • Home
  • Articles posted by AlexNovas
  • Page 38

Author: AlexNovas

Global Stem Cells Group to Move Headquarters to Larger Miami Lakes Office Complex

Global Stem Cells Group has announced plans to move its expanding network of stem cell and regenerative medicine companies to larger offices in the Miami Lakes Corporate Center.
Citing fast-paced growth and the need for more space to accommodate its expanding operations, Global Stem Cells Group CEO Benito Novas has announced plans to move the organization’s headquarters from Sunrise, Florida to the Miami Lakes Corporate Center. The new location more than doubles the space for the international stem cell and regenerative medicine company’s corporate offices.
Since opening in 2012 under the Regenestem brand, Global Stem Cells Group and its six operating companies have grown exponentially, establishing partnerships with stem cell clinics, hospitals, researchers and physicians in the Philippines, South America and Europe.
“The new Global Stem Cells Group facility provides state-of-the-art space for our entire team to drive innovation through our research and development initiatives, and support partnering activities with our biotechnology products and education programs,” Novas says. “We now have the space to continue the fast-paced growth of our companies and advance the development of new stem cell and regenerative medicine technologies that will benefit patients worldwide.”
The new corporate headquarters, scheduled to open January 15, 2015, are located in the Miami Lakes Corporate Center, 14750 NW 77th Court, Suite 304 Miami Lakes, FL 33016.

Read more
No Comments

New Stem Cell Research Shows Promising Results for Muscular Dystrophy

muscular dystrophy

Understanding Muscular Dystrophy

Muscular dystrophy (MD) encompasses a group of genetic disorders that cause progressive muscle weakness and loss of muscle mass. These disorders, affecting primarily skeletal muscles, can also impact respiratory and swallowing muscles, leading to severe disability over time.

Types and Impact of Muscular Dystrophy

New Stem Cell Research Shows Promising Results for Muscular Dystrophy
  Muscle fibers formed in the lab by human mesoangioblasts     (image: eurostemcell).

There are various types of muscular dystrophy, with Duchenne muscular dystrophy (DMD) being the most severe and common form, primarily affecting young boys. DMD is characterized by a genetic mutation that prevents the production of dystrophin, a crucial protein for muscle function. This deficiency leads to progressive muscle degeneration, loss of mobility, and, in many cases, premature death.

Current Treatments and Limitations

Currently, there is no cure for DMD. Treatment focuses on managing symptoms and slowing disease progression through therapies like physiotherapy and steroids. However, these treatments have limitations and often come with significant side effects.

New Stem Cell Research Shows Promising Results for Muscular Dystrophy

Potential of Stem Cell Therapies for Muscular Dystrophy

New Stem Cell Research Shows Promising Results for Muscular Dystrophy

Regeneration with Stem Cells

Stem cell research offers promising avenues for treating muscular dystrophy by targeting muscle regeneration. Studies have shown that stem cells isolated from muscle tissue, bone marrow, and blood vessels can potentially regenerate dystrophin-deficient muscle fibers in animal models.

Experimental Success with Stem Cells

Recent studies have demonstrated encouraging results in animal models of DMD. Researchers have successfully restored mobility in dogs and improved muscle function in mice by transplanting stem cells. These studies suggest that stem cells could potentially replace damaged muscle tissue and restore muscle function.

Combining Stem Cell and Gene Therapies

Emerging research also explores combining stem cell therapies with genetic correction techniques. This approach aims to correct the genetic defect responsible for DMD and stimulate muscle regeneration simultaneously, showing promising outcomes in preclinical studies.

Future Directions and Research

While the application of stem cell therapies for DMD in humans is still in its early stages, ongoing research holds significant promise. Future studies will focus on optimizing stem cell treatments, enhancing their safety and efficacy, and ultimately translating these findings into viable therapies for patients with muscular dystrophy.

Conclusion

Stem cell research represents a beacon of hope for advancing treatment options for muscular dystrophy, particularly DMD. As research progresses and clinical trials continue, the potential of stem cells to regenerate muscle tissue and improve quality of life for patients with muscular dystrophy becomes increasingly promising.

References:

  1. http://www.mayoclinic.org/diseases-conditions/muscular-dystrophy/basics/definition/con-20021240
  2. http://www.eurostemcell.org/factsheet/muscular-dystrophy-how-could-stem-cells-help
  3. https://www.mda.org/disease/duchenne-muscular-dystrophy/research
  4. http://quest.mda.org/article/scientists-bullish-stem-cells-muscle-repair
  5. http://hsci.harvard.edu/stem-cells-used-treat-muscular-dystrophy-mice
  6. https://med.stanford.edu/news/all-news/2014/12/stem-cells-faulty-in-duchenne-muscular-dystrophy.html
Read more
No Comments

Global Stem Cells Group Launches Stem Cell Conference Website Page for At-a-Glance Meeting and Conference information

stem cell conferences

Global Stem Cells Group has launched a new website page, stemcellconference.org, designed as a platform for medical professionals looking for information on GSCG and Regenestem conference schedules and meetings worldwide.

MIAMI, July  20, 2015—Global Stem Cells Group has announced the launch of stemcellconference.org, the online go-to web page for information on any of the GSCG and Cellgenic conferences or meetings worldwide. The site makes it easy for medical professionals to locate all the details available on any Global Stem Cells Group conference, with secure click-through registration capabilities straight from the site.

Upcoming events already accessible through stemcellconference.org include the Global Stem Cells Group Regenerative Medicine Symposiums to be held Sept. 3 in Santiago, Chile; Oct. 9 in Barcelona, Spain; Oct. 15 in Buenos Aires, Argentina; and March 19, 2016 in San Jose, Costa Rica.

The StemCellsConference.org page provides comprehensive details on all upcoming Global Stem Cells Group events, bios on GSCG Regenerative Medicine Symposium faculty members and presenters, product developers and other affiliates in the field of regenerative medicine, conference agendas, conference exhibitors, sponsors and partners, and more.

For more information, visit stemcellconference.org, or the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337.

About the Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/

Read more
No Comments

Global Stem Cells Group Subsidiary Stem Cell Training Announces Training Course to Take Place in Porto Alegre, Brazil

STEM CELL TRAINING, INC. AND CO-SPONSOR JORGE GIOSCIA FILHO,M.D. ANNOUNCE PLANS TO CONDUCT THE FIRST STEM CELL TRAINING COURSE IN BRAZIL OCT. 24-25, 2015. THE TRAINING CLASS WILL BE HELD IN PORTO ALEGRE.

stem cell therapies,EuroMedicom,stem cell medicine,global stem cells group,medical tourism,regenestem,

Stem Cell Training

Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.

Global Stem Cells Group and its subsidiary Stem Cell Training, Inc. have announced plans to conduct Brazil’s first ever stem cell harvesting and reintegration course Oct. 24 and 25, 2015. Through his alliance with Stem Cell Training, Inc. cardio-vascular surgeon Jorge Gioscia Filho, M.D. will conduct the Adipose and Bone Marrow Stem Cell Training Course for medical professionals in his home town of Poro Alegre.

In addition to his work in vascular and endovascular surgery, Filho has specialized in medical genital aesthetics in his private practice for more than 10 years. He is a member and professor at the Postgraduate Course in Aesthetic Medicine of IAAM-ASIME. Member of the International Society for Sexual Medicine and Vice President of the Southern Region of the Brazilian Society for Sexual Medicine, a member of the Brazilian Society of Angiology and Vascular Surgery, and a member of the International Society for Endovascular Specialists.

The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process through an intensive, hands-on training session to arm participating physicians with clinical protocols and state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells.

The objective of the training is to bridge the gap between bench science in the laboratory and the doctor’s office by teaching effective, in-office regenerative medicine techniques.

Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.
For more information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337.

About Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/

About Stem Cell Training, Inc.:

Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.

The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide

Read more
No Comments

Global Stem Cells Group Announces Plans to Hold International Symposium on Stem Cells and Regenerative Medicine in Santiago, Chile Sept. 3-4, 2015

The Global Stem Cells Group, Inc. has announced plans to host an international symposium on stem cells and regenerative medicine in Santiago, Chile Sept. 3-4, 2015. The Chile symposium is one of four to be hosted by GSCG this year in Latin America.
stemlab,stem cells, stem cell therapies,liposculpture,plastic surgery

Global Stem Cells Group

The symposium will feature some of the world’s most prominent scientific experts in stem cell and regenerative medicine.

Global Stem Cells Group has announced plans to host an international symposium on stem cell research in Santiago, Chile. The symposium will feature some of the world’s most prominent scientific experts in stem cell and regenerative medicine, who will provide a full day of high-level scientific discussion for medical professionals in general practice.

The symposium agenda will include sessions on:

  • Molecular biology
  • Clinical advances in stem cell research
  • Models of treatment in surgical and cosmetic applications, and in clinical conditions
  • Technological advances
  • Application of minimally manipulated stem cells in the physician’s office
  • Stem cells, regenerative medicine and its application in anti-aging medicine
  • Medical legal issues

The Santiago, Chile symposium includes a full day, hands-on training session to provide participating physicians and qualified medical professionals with state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells, along with clinical protocols. This popular training course is part of the Global Stem Cells Group’s commitment to the growing network of world-class stem cell researchers, treatment practitioners and investors committed to advancing stem cell medicine, and helping physicians bring treatments into the office for the benefit of patients.

The Santiago symposium will be held at Santo Tomas University in Santiago, Chile, and hosted by the Dean of Health Services Faculty, Fernando Espina Otero, M.D.

For more information on the Global Stem Cells Group Santiago, Chile symposium including the lineup of speakers, visit the stemcellconference.org website, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337.

About the Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/

Read more
No Comments

Stem cells may be used for healing damaged lungs

lungs

Healing Damaged Lungs with Stem Cells

A new study from the Weizmann Institute of Science reveals promising results using stem cells to repair damaged lung tissue. This breakthrough offers hope for treating conditions like bronchitis, asthma, cystic fibrosis, and emphysema, which collectively affect millions globally.

Bone Marrow Stem Cells for Lung Tissue Regeneration

Stem cells may be used for healing damaged lungs

The study focuses on similarities between lung and bone marrow stem cells. Researchers at the Weizmann Institute, led by Professor Yair Reisner, successfully transplanted bone marrow stem cells into mice with lung damage. These stem cells migrated to damaged areas, differentiated into lung tissue, and continued to generate new cells up to 16 weeks post-transplantation.

Future Directions: Lung-Specific Induced Pluripotent Stem Cells (iPSCs)

Advantages of iPSCs Over Bone Marrow Stem Cells

Stem cells may be used for healing damaged lungs
  Mouse iPSCs generated using the microRNA method   pioneered by the Morrisey Lab. The green                       fluorescence reveals expression of the Oct4 gene,         (Image: Science Daily).

In related research, scientists at Boston University Medical Center generated lung-disease specific induced pluripotent stem cells (iPSCs) from patients with conditions like emphysema and cystic fibrosis. iPSCs offer advantages such as easier cultivation and genetic compatibility, minimizing the risk of rejection in transplants.

Potential for Transplantation and Lung Tissue Differentiation

Studies show that iPSCs can differentiate into endoderm cells, precursors to lung tissue, offering a promising avenue for future treatments of lung diseases.

Conclusion

The research underscores the potential of stem cells, both from bone marrow and induced pluripotent sources, to revolutionize the treatment of lung diseases. Ongoing studies aim to refine these techniques and explore the creation of a bank of lung-specific stem cells for clinical use.

References

  1. Chava Rosen, Elias Shezen, Anna Aronovich, Yael Zlotnikov Klionsky et al. – Preconditioning allows engraftment of mouse and human embryonic lung cells, enabling lung repair in mice, Nature Medicine, 2015, Link.
  2. Aba Somers, Jyh-Chang Jean, Cesar A. Sommer, Amel Omari et al. – Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette, Stem Cells, 2010, 28 (10):1728, Link.

This structure ensures each section is clearly delineated for SEO purposes, incorporating keywords like “stem cells,” “lung tissue regeneration,” “induced pluripotent stem cells,” and specific study references.

Read more
5 Comments

Adult tissues that serve as sources for stem cells

Where Do Adult Stem Cells Come From?

Adult stem cells are garnering significant interest in the scientific community due to their ability to self-renew and differentiate into various types of cells and tissues. Unlike embryonic stem cells, which can differentiate into multiple cell types, adult stem cells typically generate tissues specific to their origin. This focus on adult stem cells has intensified amidst ethical concerns surrounding embryonic stem cell research, making them pivotal in the study of degenerative conditions such as osteoarthritis, muscular dystrophy, and Alzheimer’s disease.

Sources of Adult Stem Cells

Adult stem cells are found in several tissues, each offering potential therapeutic applications:

Neural Stem Cells (NSCs)

Neural stem cells are multipotent cells that can generate the central nervous system. Recent studies, including research by Japanese scientists, demonstrate their potential to replace dying neurons in conditions like multiple sclerosis and Parkinson’s disease [1].

Hematopoietic Stem Cells (HSCs)

Hematopoietic stem cells, derived from blood or bone marrow, can differentiate into various specialized cells such as white blood cells and red blood cells. They play a crucial role in immune response and blood clotting.

Skeletal Stem Cells (STCs)

Found in bone marrow, skeletal stem cells give rise to bone cells (osteoblasts), cartilage, and hematopoietic stroma, supporting bone structure and function.

Intestinal Stem Cells (ISCs)

ISCs, located in the lining of the intestines, continuously divide throughout life. They are implicated in intestinal cancer development but also offer regenerative potential for treating gastrointestinal disorders.

Liver Stem Cells

In the liver, hepatocytes exhibit stem cell-like behavior during regeneration, replacing damaged tissue. Researchers, such as Dr. Lola Reid, have identified biliary tree stem cells as potential pancreatic precursors, offering insights into diabetes treatment [2].

Conclusion

Research into adult stem cells has expanded our understanding of their therapeutic potential in regenerative medicine. Their diverse sources—from neural tissues to the liver—provide avenues for developing treatments without the ethical concerns associated with embryonic stem cells. With lower rejection rates and higher differentiation capabilities, adult stem cells offer hope for effectively treating degenerative diseases in the future.

References

  1. MacKlis, Jeffrey D.; Magavi, Sanjay S.; Leavitt, Blair R. (2000). “Induction of neurogenesis in the neocortex of adult mice”. Nature 405 (6789): 951–5.
  2. Biliary Tree Stem Cells, Precursors to Pancreatic Committed Progenitors: Evidence for Possible Life-long Pancreatic Organogenesis – Link.

This structure enhances readability and SEO by incorporating targeted keywords like “adult stem cells,” “neural stem cells,” “hematopoietic stem cells,” and specific study references.

Read more
No Comments

Global Stem Cells Group to Participate in the 15th International Congress of Aesthetic Surgery in Boca del Rio, Veracruz

More than 1,500 aesthetic surgeons and specialists in the fields of anti-aging and regenerative medicine from around the globe will attend the four day event.

Charles Mahl, M.D. and David B. Audley will representGlobal Stem Cells Group, Inc. as keynote speakers at the 15th International Congress of Aesthetic Surgeryin Boca del Rio in Veracruz, Mexico July 9-12, 2015. Mahl, a member of the Global Stem Cells Group Scientific Advisory Board, and Audley, the chairman and general secretary of the Regentech Alliance (RTA), will join more than 1,500 aesthetic surgeons and specialists in the fields of anti-aging and regenerative medicine from around the globe for the four day event.

Hosted by the Instituto de Estudios Superiores en Medicina (Institute of Advanced Studies in Medicine) in Veracruz, conference attendees will include an international lineup of physicians and medical practitioners in a variety of disciplines who will gather to discuss the newest therapies, protocols and innovative procedures available in aesthetic medicine.

Mahl, who maintains an active practice in regenerative medicine, preventive aging and pain therapies, will bring his expertise in prolotherapy, platelet rich plasma injections and stem cell therapies to the conference. Audley is a pioneer in the field of regenerative medicine and the founding executive director of the International Cellular Medicine Society (ICMS), the first professional medical association dedicated to the development of standards and accreditation for medical facilities engaged in cell-based therapies.
The conference will feature workshops in botulinum toxin applications for beginners and advanced students, and peeling treatments for stretch marks. Some of the topics to be addressed at the event include updates in aesthetic surgery, regenerative medicine therapies, platelet rich plasma applications, clinical and therapeutic stem cell applications, facial fillings, COFEPRIS guidelines, legal issues associated with aesthetic surgery and more.

The conference will take place at the Hotel Galerias Plaza Veracruz, Blvd. Adolfo Ruiz Cortines #3495, Costa Verde, Boca Del Río, Veracruz. For more information on the 15th International Congress of Aesthetic Surgery, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com or call 305-560-5337.

About Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/

About Charles Mahl, M.D.:
Charles F. Mahl, M.D. is a Miami-based specialist in regenerative medicine, preventive aging and pain therapies. His expertise includes prolotherapy, platelet rich plasma injections and stem cell therapies for a variety of painful orthopedic conditions and injuries involving (but not limited to) the back, sacroiliac joints, hips, knees, shoulders and neck. Mahl’s background as a vitreo-retinal surgeon prior to his training in regenerative medicine makes him eminently qualified to perform stem cell therapies on the eyes.
A member of the Global Stem Cells Group Scientific Advisory Board, Mahl sees stem cell therapies as medicine’s new frontier, offering unlimited possibilities for easing and eliminating many forms of disease and injury-related pain. He is licensed to practice medicine in Florida and Board Certified in Integrative Medicine. Mahl has completed multiple fellowships in age management medicine, and spent more than two years in a mentorship program for prolotherapy and regenerative injection medicine with Alvin Stein, M.D., a relationship that continues to this day. For Mahl’s full bio, visit http://www.stemcellsgroup.com/advisory-board/.

About David B. Audley:
David B. Audley serves as the Chair and General Secretary of the Regentech Alliance (RTA), a 501(c)3 backed by individuals and institutions who support the Regentech mission to bring peer oversight and transparency to the field of cell-based and regenerative medicine. Audley is a pioneer in the emerging field of regenerative medicine, and the founding executive director of the International Cellular Medicine Society (ICMS), the first professional medical association dedicated to the development of standards and accreditation for medical facilities engaged in cell-based therapies. Audley has taken a leadership role in drafting international standards and governmental regulations for the Cayman Islands and the Bahamas, and has worked with regulators in Mexico, the Kingdom of Jordan, and China to provide frameworks for physicians. Audley is a well-known lecturer who has spoken widely on varying topics dealing with the trends in patient care, the importance of oversight for investigational therapies, the emergence of regenerative medicine and the global and regulatory issues associated with medical tourism. For more information, visit http://regen-tech.org.

Read more
No Comments

Global Stem Cells Group, Stem Cell Training and Anti-aging Medicine Specialist John P. Salerno, M.D. to Hold Training Course in Manhattan

The course will focus on stem cell therapies for a variety of conditions and treatments including anti-aging therapies.

MIAMI (PRWEB) June 08, 2015

Global Stem Cells Group and its subsidiary Stem Cell Training, Inc. have announced plans to conduct a hands-on, two day intensive stem cell training course for physicians and qualified medical professionals Sept. 18 -19, 2015. The training course will be led by anti-aging specialist John P. Salerno, M.D. in Midtown Manhattan.

The founder of The Salerno Center, Salerno practices integrative medicine, combining traditional and alternative healing methods. The course will focus on stem cell therapies for a variety of conditions and treatments including anti-aging therapies. Salerno trained in anti-aging medicine and has opened more than 20 anti-aging medical centers worldwide, including 10 in Japan, three in Brazil and two in Korea.

The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process through an intensive, hands-on training session that arms participants with clinical protocols and state-of-the-art techniques for isolating and re-integrating adipose- and bone marrow-derived stem cells.

The objective of the training is to teach effective regenerative medicine techniques that can be used to treat patients in-office.

Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.

For more information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337.

About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/

About Stem Cell Training, Inc.:
Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.

The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.

About John P. Salerno, M.D.:
The go-to doctor for professional, comprehensive and full-service care, John P. Salerno, M.D. offers life-changing health solutions and educates both patients and physicians on the benefits of health, wellness and complementary medicine with a specialized focus in vitamin IV therapy, heavy metal detox, weight loss, anti-aging medicine, allergies and hair loss. A former partner of the late Robert C. Atkins, M.D. of “The Atkins Diet” fame, Salerno created and developed his own award-winning diet called “The Silver Cloud Diet,” launching a worldwide movement for patients and physicians to grow, heal, and learn.
Salerno’s cutting-edge medical approach incorporates observation and state-of-the-art testing, enabling him to pioneer an exclusive treatment plan that is restorative and beneficial. Salerno is the author of two top-selling diet and lifestyle books,“Fight Fat with Fat” and “The Salerno Solution,” as well as a popular lecturer, radio host and global media icon.

Read more
No Comments

Global Stem Cells Group and Marina Medical Announce Agreement to Conduct Stem Cell Training Courses Worldwide

Global Stem Cells Group and Marina Medical, Inc. announce plans to conduct joint stem cell training courses worldwide. GSCG subsidiary Adimarket will distribute stem cell products to Latin America in conjunction with the joint training program.

Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries.

MIAMI, June 4, 2015—Global Stem Cells Group and Marina Medical, Inc. have announced plans to conduct joint stem cell training courses for physicians and qualified medical professionals worldwide. Sunrise, Florida-based Marina Medical is an established leader in design, manufacture and distribution of medical devices for OBGYN, plastic and aesthetic surgery, regenerative medicine and urogynecology.
Marina Medical’s recently launched Koume Cannalus division manufactures instruments for regenerative medicine procedures. Teaming with GSCG for the stem cell training courses will help to further stem cell education among those medical professionals who use Marina Medical instruments.

Global Stem Cells Group subsidiary Adimarket will provide regenerative medicine equipment and supplies for the joint training session held in Latin America.

The Adipose and Bone Marrow Stem Cell Training Course was developed for physicians and high-level practitioners to learn the process of isolating and re-integrating adipose- and bone marrow-derived stem cells through an intensive, hands-on training session. The objective is to arm participating physicians with clinical protocols and state-of-the-art techniques so that they can bring regenerative medicine therapies to their patients in-office.

Global Stem Cells Group’s Stem Cell Training, Inc. courses have been extended to approximately 35 countries, allowing a global community of physicians to learn how to apply these new stem cell technologies.

For more information, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337.

About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine. Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. Each of GSCG’s six operating companies focus on a separate research-based mission; the result is a global network of state-of-the-art stem cell treatments and facilities.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/

About Marina Medical, Inc.:
Since 1998, Marina Medical has been an established leader in the design, development and distribution of surgical instrumentation for OBGYN and plastic surgery. Customers receive access to educational materials, special offers, a rewards program, residents’ program and innovative surgical instrumentation and equipment. Through its newKoume Cannula division, Marina Medical manufactures instruments designed specifically for regenerative medicine procedures.

About Adimarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.
Adimarket was founded to provide physicians and other health care professionals the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact the practice of stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting edge treatments.

Read more
No Comments

Send Us a Message

TOP